Inhibition of DNA Virus: Herpes-1 (HSV-1) in cellular culture replication, through an antioxidant treatment extracted from rosemary spice

被引:9
|
作者
Portari Mancini, Dalva Assuncao [1 ]
Torres, Rosangela Pavan [2 ]
Pinto, Jose Ricardo [1 ]
Mancini-Filho, Jorge [2 ]
机构
[1] Univ Sao Paulo, Virol Lab, Div Sci Dev, Butantan Inst, BR-05503900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Lipids Lab, Dept Food Sci & Nutr, Fac Pharmaceut Sci, BR-05503900 Sao Paulo, Brazil
关键词
Herpesvirus; Natural antioxidants; Phenolic compounds; Rosemary; Virus replication;
D O I
10.1590/S1984-82502009000100016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work aimed to evaluate antiviral properties in antioxidants from spices. Phenolic Compounds extracted from rosemary (Rosmarinus officinallis, L) by hot water, had their antioxidant activity determined by spectrophotometry using beta carotene/linoleic acid system. The rosemary extract was evaluated by antiviral assay of Herpes Virus type-1 (HSV-1) replication in VERO cells, in the presence or absence of the spice. 10,000 TCID50/mL of the HSV-1 was kept for 3 h at 4 degrees C, with 300 ppm of rosemary extract, and 100 ppm of butyl hydroxyl toluene (BHT). Then, these viruses were inoculated in VERO cells incubated at 37 degrees C in CO2-5%, for seven days. Daily, they were examined and the end point was based on 100% of CPE in virus control (without antioxidants). The HSV-1 replication inhibition percentage (IP) measured the antiviral action from antioxidants, showing viral reductions of the 82.0, 82.5%, in the presence of rosemary and rosemary + BHT, respectively. As an extension, cell test corresponded to the similar viral decrease (IP = 85.0 and 86.3%) in both aforementioned situations. Results lead to Conclude that phenolic compounds from rosemary revealed an antiviral action on herpesvirus-1.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 50 条
  • [1] Control of cellular gene expression during herpes simplex virus 1 (HSV-1) replication
    Roizman, Bernard
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 32 - 32
  • [2] Herpes simplex virus 1 (HSV-1) for cancer treatment
    Shen, Y.
    Nemunaitis, J.
    CANCER GENE THERAPY, 2006, 13 (11) : 975 - 992
  • [3] Herpes simplex virus 1 (HSV-1) for cancer treatment
    Y Shen
    J Nemunaitis
    Cancer Gene Therapy, 2006, 13 : 975 - 992
  • [4] INHIBITION OF HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION BY INOSITOL-REQUIRING ENZYME 1 (IRE1) PATHWAY
    Su, A. R.
    Wang, X. H.
    Wu, Z. W.
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A171 - A171
  • [5] INHIBITION OF HSV-1 AND VACCINIA VIRUS-REPLICATION BY CEPHALOSPORIN DERIVATIVES
    COTTAGNOUD, P
    NEFTEL, KA
    HANY, M
    ZINKERNAGEL, RM
    ANTIVIRAL RESEARCH, 1988, 10 (1-3) : 59 - 70
  • [6] The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation
    Kent, JR
    Fraser, NW
    JOURNAL OF NEUROVIROLOGY, 2005, 11 (04) : 376 - 383
  • [7] The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation
    J. R. Kent
    N. W. Fraser
    Journal of NeuroVirology, 2005, 11 : 376 - 383
  • [8] HSV-1 DNA Replication-Coordinated Regulation by Viral and Cellular Factors
    Packard, Jessica E.
    Dembowski, Jill A.
    VIRUSES-BASEL, 2021, 13 (10):
  • [9] Interferon (IFN)-β and IFN-γ synergize to disrupt herpes simplex virus 1 (HSV-1) replication
    Halford, WP
    Pierce, A
    DeSalvo, J
    Foster, T
    Kosinski, A
    Weller, S
    Gebhardt, B
    FASEB JOURNAL, 2005, 19 (04): : A372 - A372
  • [10] ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN
    Carson, J.
    Haddad, D.
    Bressman, M.
    Fong, Y.
    DRUGS OF THE FUTURE, 2010, 35 (03) : 183 - 195